Vivos Therapeutics, Inc. — Director's Dealing 2021

Aug 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vivos Therapeutics, Inc. (VVOS)
CIK: 0001716166
Period of Report: 2021-08-05

Reporting Person: Singh Gurdev Dave (Director, Chief Medical Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-05	Stock Option (Right to Buy)	$2.72	A	30000	Acquired	2026-08-05	Common Stock (46667)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3219705	Indirect

Footnotes

F1: Shares held by Himmat LP, of which reporting person is a member and manager.

F2: 30,000 stock options granted on August 5, 2021. One-half vested immediately and one-eighth vests quarterly every three months through August 5, 2022.